Immucell's total assets for Q3 2024 were $44.45M, an increase of 6.20% from the previous quarter. ICCC total liabilities were $18.04M for the fiscal quarter, a -1.97% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.